Premium
A PHASE 1B/2 STUDY OF ORAL NANATINOSTAT (N) AND VALGANCICLOVIR (VG) IN SUBJECTS WITH EPSTEIN‐BARR VIRUS (EBV)‐ASSOCIATED LYMPHOMAS
Author(s) -
Porcu P.,
Haverkos B.,
Brem E.,
Vallurupalli A.,
Feldman T.,
Alpdogan O.,
Brammer J.,
Bryan L.J.,
Barta S.,
Schriefer A.,
Obrzut S.,
Shen H.,
Rochford R.,
Baiocchi R.,
Casper C.,
Gutheil J.,
Melink T.,
Kearns C.,
Burner D.,
McRae R.,
Daniels P.,
Warren M.S.,
Woody J.,
Royston I.,
Faller D.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.148_2630
Subject(s) - medicine , neutropenia , lymphoma , gastroenterology , oncology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom